Shoucheng Expands Robotics Retail Footprint Ahead of Lunar New Year, Opens Three Beijing Stores 
Metavista3D Files New Patent Application for Automotive Display Technology 
SuperQ Secures Strategic European Foothold via Landmark Partnership with Fraunhofer Institute for Industrial Mathematics ITWM; Positions for Global Dominance in Hybrid Quantum 
Paul Advisory & Legal Group Introduces Equity Stripping and Offshore Trusts as Key Asset Protection Strategies, Changing the Economics of Litigation 
Genviral Releases OpenClaw Skill to Automate Social Media Content Across Six Platforms Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Bioasis Announces $200,000 Non-Brokered Private Placement
NEW HAVEN, Conn., Feb. 17, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Converge Technology Solutions Reports Strong Preliminary Q4-2021 Results
TORONTO and GATINEAU, Québec, Feb. 17, 2022 (GLOBE NEWSWIRE) — Converge Technology Solutions Corp. (“Converge”…
BitZERO Announces Kevin O’Leary and Phoenix Group as Strategic Investors
Vancouver, British Columbia–(Newsfile Corp. – February 17, 2022) – BitZERO Blockchain Inc. (“BitZERO” or the…
Coherus BioSciences Reports Fourth Quarter and Full Year 2021 Results
– YUSIMRY™ (adalimumab-aqvh), Coherus’ second product, approved by FDA on December 17, 2021 –– BLAs…
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth…
Agios Announces FDA Approval of PYRUKYND® (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
Kim Hall Kim Hall, Living with PK Deficiency – Approval Based on Results from ACTIVATE…
Sorrento Announces That It Has Acquired a Majority Ownership in Diagnostic Manufacturer Zhengzhou Fortune Bioscience in Response to Increasing Worldwide Demand For COVISTIX™
COVISTIX is a highly sensitive and rapid antigen detection test for SARS-CoV-2 and its major…
Bectran Inc Awarded TRUSTe Privacy Certification Seal, Demonstrating Commitment to International Data Protection
CHICAGO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Credit, Collections & Accounts Receivable Software leader Bectran,…
Boise Cascade Announces Executive Leadership Promotions
BOISE, Idaho–(BUSINESS WIRE)–Boise Cascade Company (Boise Cascade) (NYSE: BCC) today announced the promotion of three…
Red River Recognized as an Elite 150 on CRN’s 2022 MSP 500 List
CLAREMONT, N.H. & CHANTILLY, Va.–(BUSINESS WIRE)–Red River, a technology transformation company, announced today that CRN®,…
South American Education Program Expands Utilization of PowerSchool Solutions to Nearly 1 Million Uruguayan Students
Plan Ceibal initiative improves regular instruction, student performance monitoring, and hybrid learning capabilities for 800,000…
Faraday Future Receives Intelligent Manufacturing Equipment from Guangzhou MINO Equipment at Its Hanford Manufacturing Facility, Setting the Stage for FF 91 Delivery in Q3 of 2022
FF has worked closely with Guangzhou MINO Equipment to develop manufacturing equipment specific to the…
Pairwise Welcomes Wendy Webb Williams as General Counsel and VP, Operations
Former Chief Legal Officer at Sara Lee Frozen Bakery will bring over two decades of…
Nomad Raises $20M to Unlock Financial Opportunity in the Long-Term Rental Space
Denver-based proptech startup plans to expand its guaranteed rent program and brokerage services to 10…
COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February 2022
LONDON, United Kingdom, Feb. 17, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a…
OSE Immunotherapeutics is Pleased to Announce that Veloxis Pharmaceuticals, Inc., its Partner in Transplantation, has Obtained FDA Fast-Track Designation for CD28 Antagonist VEL-101/FR104
NANTES, France, Feb. 17, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)…
Ushur Reports a Breakout Year in Customer Experience Automation
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — Ushur, the leader in AI-powered Customer…
iZUMi Finance Launches Revolutionary DAO With veNFT Governance Based on Quadratic Voting
Singapore, Singapore–(Newsfile Corp. – February 17, 2022) – izumi Finance, the innovative protocol that provides…